Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
22.2%
% of GERM's 54 holdings also in IDNA
25.5%
% of IDNA's 51 holdings also in GERM
Overlap by Weight
Sector Drift (GERM minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GERM |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
MODERNA, INC. | 7.3% | 5.0% | 5.0% | |
BIONTECH SE SPONSORED ADR | 6.5% | 3.4% | 3.4% | |
DYNAVAX TECHNOLOGIES CORP | 4.0% | 2.0% | 2.0% | |
BIOCRYST PHARMACEUTICALS INC | 2.4% | 1.2% | 1.2% | |
VIR BIOTECHNOLOGY, INC. | 2.8% | 0.9% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
GERM Overweight Relative to IDNA
QUEST DIAGNOSTICS | 6.8% | |
ALNYLAM PHARMACEUTICALS INC | 6.3% | |
LABORATORY CRP OF AMER HLDGS | 6.2% | |
IMMUNITYBIO INC | 4.0% | |
BIO-RAD LABORATORIES-CL A | 3.8% | |
QUIDEL CORP | 3.8% | |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | 3.7% | |
VAXCYTE, INC. | 3.6% | |
BIONTECH SE SPONSORED ADR | 3.1% | |
ZAI LAB LTD. UNSPONSORED ADR | 3.0% |
GERM Underweight Relative to IDNA
REVOLUTION MEDICINES, INC. | -5.6% | |
SAREPTA THERAPEUTICS INC | -5.3% | |
EXELIXIS INC | -4.0% | |
SANOFI-AVENTIS | -3.9% | |
MERCK & CO. INC. | -3.8% | |
INCYTE CORP | -3.8% | |
TAKEDA PHARMACEUTICAL CO LTD | -3.6% | |
GENMAB A/S | -3.6% | |
ROCHE HOLDING LTD | -3.5% | |
REGENERON PHARMACEUTICALS | -3.4% |